These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 25963852)
1. Childhood cancers in families with and without Lynch syndrome. Heath JA; Reece JC; Buchanan DD; Casey G; Durno CA; Gallinger S; Haile RW; Newcomb PA; Potter JD; Thibodeau SN; Le Marchand L; Lindor NM; Hopper JL; Jenkins MA; Win AK Fam Cancer; 2015 Dec; 14(4):545-51. PubMed ID: 25963852 [TBL] [Abstract][Full Text] [Related]
2. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2. Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011 [TBL] [Abstract][Full Text] [Related]
4. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
6. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217 [TBL] [Abstract][Full Text] [Related]
7. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451 [TBL] [Abstract][Full Text] [Related]
8. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome. Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families. Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C; Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211 [TBL] [Abstract][Full Text] [Related]
10. Risk of cancer in cases of suspected lynch syndrome without germline mutation. Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017 [TBL] [Abstract][Full Text] [Related]
11. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458 [TBL] [Abstract][Full Text] [Related]
12. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533 [TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome and cervical cancer. Antill YC; Dowty JG; Win AK; Thompson T; Walsh MD; Cummings MC; Gallinger S; Lindor NM; Le Marchand L; Hopper JL; Newcomb PA; Haile RW; Church J; Tucker KM; Buchanan DD; Young JP; Winship IM; Jenkins MA Int J Cancer; 2015 Dec; 137(11):2757-61. PubMed ID: 26077226 [TBL] [Abstract][Full Text] [Related]
14. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations. Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Peltomäki P Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998 [TBL] [Abstract][Full Text] [Related]
16. [A novel genetic disorder of Lynch syndrome - EPCAM gene deletion]. Tomita N; Yamano T; Matsubara N; Tamura K Gan To Kagaku Ryoho; 2013 Feb; 40(2):143-7. PubMed ID: 23411950 [TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion. Lynch HT; Riegert-Johnson DL; Snyder C; Lynch JF; Hagenkord J; Boland CR; Rhees J; Thibodeau SN; Boardman LA; Davies J; Kuiper RP; Hoogerbrugge N; Ligtenberg MJ Am J Gastroenterol; 2011 Oct; 106(10):1829-36. PubMed ID: 21769135 [TBL] [Abstract][Full Text] [Related]
18. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
19. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
20. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]. See WA Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]